Tumor-specific activation of an EGFR-targeting probody enhances therapeutic index.
Sci Transl Med. 2013 Oct 16;5(207):207ra144. doi: 10.1126/scitranslmed.3006682.
Sci Transl Med. 2013.
PMID: 24132639